NORTH AMERICA CANCER TREATMENT DRUGS MARKET BY MANUFACTURERS, COUNTRIES, TYPE AND APPLICATION, FORECAST TO 2022

Jan 2018 121
Table of Contents

1 Market Overview
1.1 Cancer Treatment Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Chemotherapy
1.2.2 Targeted Therapy
1.2.3 Immunotherapy
1.2.4 Hormonal Therapy (Biologic Therapy)
1.2.5 Others
1.3 Market Analysis by Applications
1.3.1 Blood Cancer
1.3.2 Breast Cancer
1.3.3 Gastrointestinal Cancer
1.3.4 Prostate Cancer
1.3.5 Respiratory/Lung Cancer
1.3.6 Other Cancers
1.4 Market Analysis by Countries
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 Mexico Status and Prospect (2012-2022)
1.4.3 Canada Status and Prospect (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force

2 Manufacturers Profiles
2.1 Roche
2.1.1 Profile
2.1.2 Cancer Treatment Drugs Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Roche Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.4 Business Overview
2.1.5 Roche News
2.2 Novartis
2.2.1 Profile
2.2.2 Cancer Treatment Drugs Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Novartis Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.4 Business Overview
2.2.5 Novartis News
2.3 Celgene
2.3.1 Profile
2.3.2 Cancer Treatment Drugs Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Celgene Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.4 Business Overview
2.3.5 Celgene News
2.4 Bristol-Myers Squibb
2.4.1 Profile
2.4.2 Cancer Treatment Drugs Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Bristol-Myers Squibb Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.4 Business Overview
2.4.5 Bristol-Myers Squibb News
2.5 Amgen
2.5.1 Profile
2.5.2 Cancer Treatment Drugs Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Amgen Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.4 Business Overview
2.5.5 Amgen News
2.6 Johnson & Johnson
2.6.1 Profile
2.6.2 Cancer Treatment Drugs Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Johnson & Johnson Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.4 Business Overview
2.6.5 Johnson & Johnson News
2.7 Pfizer
2.7.1 Profile
2.7.2 Cancer Treatment Drugs Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Pfizer Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.4 Business Overview
2.7.5 Pfizer News
2.8 Takeda
2.8.1 Profile
2.8.2 Cancer Treatment Drugs Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 Takeda Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.4 Business Overview
2.8.5 Takeda News
2.9 Eli Lilly
2.9.1 Profile
2.9.2 Cancer Treatment Drugs Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Eli Lilly Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.4 Business Overview
2.9.5 Eli Lilly News
2.10 AstraZeneca
2.10.1 Profile
2.10.2 Cancer Treatment Drugs Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 AstraZeneca Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.4 Business Overview
2.10.5 AstraZeneca News
2.11 Astellas
2.11.1 Profile
2.11.2 Cancer Treatment Drugs Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 Astellas Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11.4 Business Overview
2.11.5 Astellas News
2.12 Merck & Co.
2.12.1 Profile
2.12.2 Cancer Treatment Drugs Type and Applications
2.12.2.1 Type 1
2.12.2.2 Type 2
2.12.3 Merck & Co. Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12.4 Business Overview
2.12.5 Merck & Co. News
2.13 Sanofi
2.13.1 Profile
2.13.2 Cancer Treatment Drugs Type and Applications
2.13.2.1 Type 1
2.13.2.2 Type 2
2.13.3 Sanofi Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13.4 Business Overview
2.13.5 Sanofi News
2.14 Bayer
2.14.1 Profile
2.14.2 Cancer Treatment Drugs Type and Applications
2.14.2.1 Type 1
2.14.2.2 Type 2
2.14.3 Bayer Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14.4 Business Overview
2.14.5 Bayer News
2.15 Biogen Idec
2.15.1 Profile
2.15.2 Cancer Treatment Drugs Type and Applications
2.15.2.1 Type 1
.2.2 Type 2
2.15.3 Biogen Idec Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15.4 Business Overview
2.15.5 Biogen Idec News
2.16 Eisai
2.16.1 Profile
2.16.2 Cancer Treatment Drugs Type and Applications
2.16.2.1 Type 1
2.16.2.2 Type 2
2.16.3 Eisai Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16.4 Business Overview
2.16.5 Eisai News
2.17 Teva
2.17.1 Profile
2.17.2 Cancer Treatment Drugs Type and Applications
2.17.2.1 Type 1
2.17.2.2 Type 2
2.17.3 Teva Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17.4 Business Overview
2.17.5 Teva News
2.18 Otsuka
2.18.1 Profile
2.18.2 Cancer Treatment Drugs Type and Applications
2.18.2.1 Type 1
2.18.2.2 Type 2
2.18.3 Otsuka Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18.4 Business Overview
2.18.5 Otsuka News
2.19 Merck KGaA
2.19.1 Profile
2.19.2 Cancer Treatment Drugs Type and Applications
2.19.2.1 Type 1
2.19.2.2 Type 2
2.19.3 Merck KGaA Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.19.4 Business Overview
2.19.5 Merck KGaA News
2.20 Ipsen
2.20.1 Profile
2.20.2 Cancer Treatment Drugs Type and Applications
2.20.2.1 Type 1
2.20.2.2 Type 2
2.20.3 Ipsen Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.20.4 Business Overview
2.20.5 Ipsen News
2.21 AbbVie
2.21.1 Profile
2.21.2 Cancer Treatment Drugs Type and Applications
2.21.2.1 Type 1
2.21.2.2 Type 2
2.21.3 AbbVie Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.21.4 Business Overview
2.21.5 AbbVie News
2.22 Gilead Sciences
2.22.1 Profile
2.22.2 Cancer Treatment Drugs Type and Applications
2.22.2.1 Type 1
2.22.2.2 Type 2
2.22.3 Gilead Sciences Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.22.4 Business Overview
2.22.5 Gilead Sciences News

3 North America Cancer Treatment Drugs Market Competition, by Manufacturer
3.1 North America Cancer Treatment Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 North America Cancer Treatment Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 North America Cancer Treatment Drugs Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Cancer Treatment Drugs Manufacturer Market Share
3.4.2 Top 5 Cancer Treatment Drugs Manufacturer Market Share
3.5 Market Competition Trend

4 North America Cancer Treatment Drugs Market Analysis by Countries
4.1 North America Cancer Treatment Drugs Sales Market Share by Countries
4.2 North America Cancer Treatment Drugs Sales by Countries (2012-2017)
4.3 North America Cancer Treatment Drugs Revenue (Value) by Countries (2012-2017)

5 North America Market Segmentation Cancer Treatment Drugs by Type
5.1 North America Cancer Treatment Drugs Sales, Revenue and Market Share by Type (2012-2017)
5.1.1 North America Cancer Treatment Drugs Sales and Market Share by Type (2012-2017)
5.1.2 North America Cancer Treatment Drugs Revenue and Market Share by Type (2012-2017)
5.2 Chemotherapy Sales Growth and Price
5.2.1 North America Chemotherapy Sales Growth (2012-2017)
5.2.2 North America Chemotherapy Price (2012-2017)
5.3 Targeted Therapy Sales Growth and Price
5.3.1 North America Targeted Therapy Sales Growth (2012-2017)
5.3.2 North America Targeted Therapy Price (2012-2017)
5.4 Immunotherapy Sales Growth and Price
5.4.1 North America Immunotherapy Sales Growth (2012-2017)
5.4.2 North America Immunotherapy Price (2012-2017)
5.5 Hormonal Therapy (Biologic Therapy) Sales Growth and Price
5.5.1 North America Hormonal Therapy (Biologic Therapy) Sales Growth (2012-2017)
5.5.2 North America Hormonal Therapy (Biologic Therapy) Price (2012-2017)
5.6 Others Sales Growth and Price
5.6.1 North America Others Sales Growth (2012-2017)
5.6.2 North America Others Price (2012-2017)

6 North America Market Segmentation Cancer Treatment Drugs by Application
6.1 North America Cancer Treatment Drugs Sales Market Share by Application (2012-2017)
6.2 Blood Cancer Sales Growth (2012-2017)
6.3 Breast Cancer Sales Growth (2012-2017)
6.4 Gastrointestinal Cancer Sales Growth (2012-2017)
6.5 Prostate Cancer Sales Growth (2012-2017)
6.6 Respiratory/Lung Cancer Sales Growth (2012-2017)
6.7 Other Cancers Sales Growth (2012-2017)

7 United States Cancer Treatment Drugs Sales, Revenue, by Type, Application and Manufacturers
7.1 United States Cancer Treatment Drugs Revenue, Sales and Growth Rate (2012-2017)
7.2 United States Cancer Treatment Drugs Sales and Market Share by Type
7.3 United States Cancer Treatment Drugs Sales by Application (2012-2017)
7.4 United States Cancer Treatment Drugs Sales, Revenue and Market Share by Manufacturer
7.4.1 United States Cancer Treatment Drugs Sales and Market Share by Manufacturer
7.4.2 United States Cancer Treatment Drugs Revenue and Market Share by Manufacturer
7.5 United States Cancer Treatment Drugs Export and Import (2012-2017)

8 Canada Cancer Treatment Drugs Sales, Revenue, by Type, Application and Manufacturers
8.1 Canada Cancer Treatment Drugs Revenue, Sales and Growth Rate (2012-2017)
8.2 Canada Cancer Treatment Drugs Sales and Market Share by Type
8.3 Canada Cancer Treatment Drugs Sales by Application (2012-2017)
8.4 Canada Cancer Treatment Drugs Sales, Revenue and Market Share by Manufacturer
8.4.1 Canada Cancer Treatment Drugs Sales and Market Share by Manufacturer
8.4.2 Canada Cancer Treatment Drugs Revenue and Market Share by Manufacturer
8.5 Canada Cancer Treatment Drugs Export and Import (2012-2017)

9 Mexico Cancer Treatment Drugs Sales, Revenue, by Type, Application and Manufacturers
9.1 Mexico Cancer Treatment Drugs Revenue, Sales and Growth Rate (2012-2017)
9.2 Mexico Cancer Treatment Drugs Sales and Market Share by Type
9.3 Mexico Cancer Treatment Drugs Sales by Application (2012-2017)
9.4 Mexico Cancer Treatment Drugs Sales, Revenue and Market Share by Manufacturer
9.4.1 Mexico Cancer Treatment Drugs Sales and Market Share by Manufacturer
9.4.2 Mexico Cancer Treatment Drugs Revenue and Market Share by Manufacturer
9.5 Mexico Cancer Treatment Drugs Export and Import (2012-2017)

10 Cancer Treatment Drugs Market Forecast (2017-2022)
10.1 North America Cancer Treatment Drugs Sales, Revenue and Growth Rate (2017-2022)
10.2 Cancer Treatment Drugs Market Forecast by Countries (2017-2022)
10.2.1 United States Cancer Treatment Drugs Forecast (2017-2022)
10.2.2 Canada Cancer Treatment Drugs Forecast (2017-2022)
10.2.3 Mexico Cancer Treatment Drugs Forecast (2017-2022)
10.3 Cancer Treatment Drugs Market Forecast by Type (2017-2022)
10.4 Cancer Treatment Drugs Market Forecast by Application (2017-2022)

11 Cancer Treatment Drugs Manufacturing Cost Analysis
11.1 Cancer Treatment Drugs Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Cancer Treatment Drugs

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Cancer Treatment Drugs Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Cancer Treatment Drugs Major Manufacturers in 2016
12.4 Downstream Buyers

13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix
15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source

List of Tables and Figures

Figure Cancer Treatment Drugs Picture
Table Product Specifications of Cancer Treatment Drugs
Figure North America Sales Market Share of Cancer Treatment Drugs by Types in 2016
Table Types of Cancer Treatment Drugs
Figure Chemotherapy Picture
Table Major Manufacturers of Chemotherapy
Figure Targeted Therapy Picture
Table Major Manufacturers of Targeted Therapy
Figure Immunotherapy Picture
Table Major Manufacturers of Immunotherapy
Figure Hormonal Therapy (Biologic Therapy) Picture
Table Major Manufacturers of Hormonal Therapy (Biologic Therapy)
Figure Others Picture
Table Major Manufacturers of Others
Table North America Cancer Treatment Drugs Sales Market Share by Applications in 2016
Table Applications of Cancer Treatment Drugs
Figure Blood Cancer Picture
Figure Breast Cancer Picture
Figure Gastrointestinal Cancer Picture
Figure Prostate Cancer Picture
Figure Respiratory/Lung Cancer Picture
Figure Other Cancers Picture
Figure United States Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Mexico Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Canada Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Cancer Treatment Drugs Type and Applications
Table Roche Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Cancer Treatment Drugs Type and Applications
Table Novartis Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Celgene Basic Information, Manufacturing Base and Competitors
Table Celgene Cancer Treatment Drugs Type and Applications
Table Celgene Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Cancer Treatment Drugs Type and Applications
Table Bristol-Myers Squibb Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Cancer Treatment Drugs Type and Applications
Table Amgen Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Cancer Treatment Drugs Type and Applications
Table Johnson & Johnson Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Cancer Treatment Drugs Type and Applications
Table Pfizer Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Takeda Basic Information, Manufacturing Base and Competitors
Table Takeda Cancer Treatment Drugs Type and Applications
Table Takeda Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Cancer Treatment Drugs Type and Applications
Table Eli Lilly Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Cancer Treatment Drugs Type and Applications
Table AstraZeneca Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Astellas Basic Information, Manufacturing Base and Competitors
Table Astellas Cancer Treatment Drugs Type and Applications
Table Astellas Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck & Co. Basic Information, Manufacturing Base and Competitors
Table Merck & Co. Cancer Treatment Drugs Type and Applications
Table Merck & Co. Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Cancer Treatment Drugs Type and Applications
Table Sanofi Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Cancer Treatment Drugs Type and Applications
Table Bayer Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Biogen Idec Basic Information, Manufacturing Base and Competitors
Table Biogen Idec Cancer Treatment Drugs Type and Applications
Table Biogen Idec Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Eisai Basic Information, Manufacturing Base and Competitors
Table Eisai Cancer Treatment Drugs Type and Applications
Table Eisai Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Cancer Treatment Drugs Type and Applications
Table Teva Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Otsuka Basic Information, Manufacturing Base and Competitors
Table Otsuka Cancer Treatment Drugs Type and Applications
Table Otsuka Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck KGaA Basic Information, Manufacturing Base and Competitors
Table Merck KGaA Cancer Treatment Drugs Type and Applications
Table Merck KGaA Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Ipsen Basic Information, Manufacturing Base and Competitors
Table Ipsen Cancer Treatment Drugs Type and Applications
Table Ipsen Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AbbVie Basic Information, Manufacturing Base and Competitors
Table AbbVie Cancer Treatment Drugs Type and Applications
Table AbbVie Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table Gilead Sciences Cancer Treatment Drugs Type and Applications
Table Gilead Sciences Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table North America Cancer Treatment Drugs Sales by Manufacturer (2016-2017)
Figure North America Cancer Treatment Drugs Sales Market Share by Manufacturer in 2016
Figure North America Cancer Treatment Drugs Sales Market Share by Manufacturer in 2017
Table North America Cancer Treatment Drugs Revenue by Manufacturer (2016-2017)
Figure North America Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2016
Figure North America Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2017
Table North America Cancer Treatment Drugs Price by Manufacturers (2016-2017)
Figure Top 3 Cancer Treatment Drugs Manufacturer Market Share in 2016
Figure Top 3 Cancer Treatment Drugs Manufacturer Market Share in 2017
Figure Top 5 Cancer Treatment Drugs Manufacturer Market Share in 2016
Figure Top 5 Cancer Treatment Drugs Manufacturer Market Share in 2017
Figure North America Cancer Treatment Drugs Sales and Growth (2012-2017)
Table North America Cancer Treatment Drugs Sales by Countries (2012-2017)
Table North America Cancer Treatment Drugs Sales Market Share by Countries (2012-2017)
Figure North America 2012 Cancer Treatment Drugs Sales Market Share by Countries
Figure North America 2016 Cancer Treatment Drugs Sales Market Share by Countries
Figure North America Cancer Treatment Drugs Revenue and Growth (2012-2017)
Table North America Cancer Treatment Drugs Revenue by Countries (2012-2017)
Table North America Cancer Treatment Drugs Revenue Market Share by Countries (2012-2017)
Table North America 2012 Cancer Treatment Drugs Revenue Market Share by Countries
Table North America 2016 Cancer Treatment Drugs Revenue Market Share by Countries
Table North America Cancer Treatment Drugs Sales by Type (2012-2017)
Table North America Cancer Treatment Drugs Sales Share by Type (2012-2017)
Table North America Cancer Treatment Drugs Revenue by Type (2012-2017)
Table North America Cancer Treatment Drugs Revenue Share by Type (2012-2017)
Figure North America Chemotherapy Sales Growth (2012-2017)
Figure North America Chemotherapy Price (2012-2017)
Figure North America Targeted Therapy Sales Growth (2012-2017)
Figure North America Targeted Therapy Price (2012-2017)
Figure North America Immunotherapy Sales Growth (2012-2017)
Figure North America Immunotherapy Price (2012-2017)
Figure North America Hormonal Therapy (Biologic Therapy) Sales Growth (2012-2017)
Figure North America Hormonal Therapy (Biologic Therapy) Price (2012-2017)
Figure North America Others Sales Growth (2012-2017)
Figure North America Others Price (2012-2017)
Table North America Cancer Treatment Drugs Sales by Application (2012-2017)
Table North America Cancer Treatment Drugs Sales Share by Application (2012-2017)
Figure North America Blood Cancer Sales Growth (2012-2017)
Figure North America Breast Cancer Sales Growth (2012-2017)
Figure North America Gastrointestinal Cancer Sales Growth (2012-2017)
Figure North America Prostate Cancer Sales Growth (2012-2017)
Figure North America Respiratory/Lung Cancer Sales Growth (2012-2017)
Figure North America Other Cancers Sales Growth (2012-2017)
Figure United States Cancer Treatment Drugs Revenue and Growth (2012-2017)
Figure United States Cancer Treatment Drugs Sales and Growth (2012-2017)
Table United States Cancer Treatment Drugs Sales by Type (2012-2017)
Table United States Cancer Treatment Drugs Sales Market Share by Type (2012-2017)
Table United States Cancer Treatment Drugs Sales by Application (2012-2017)
Table United States Cancer Treatment Drugs Sales Market Share by Application (2012-2017)
Table United States Cancer Treatment Drugs Sales by Manufacturer (2016-2017)
Figure United States Cancer Treatment Drugs Sales Market Share by Manufacturer in 2016
Figure United States Cancer Treatment Drugs Sales Market Share by Manufacturer in 2017
Table United States Cancer Treatment Drugs Revenue by Manufacturer (2016-2017)
Figure United States Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2016
Figure United States Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2017
Table United States Cancer Treatment Drugs Export and Import (2012-2017)
Figure Canada Cancer Treatment Drugs Revenue and Growth (2012-2017)
Figure Canada Cancer Treatment Drugs Sales and Growth (2012-2017)
Table Canada Cancer Treatment Drugs Sales by Type (2012-2017)
Table Canada Cancer Treatment Drugs Sales Market Share by Type (2012-2017)
Table Canada Cancer Treatment Drugs Sales by Application (2012-2017)
Table Canada Cancer Treatment Drugs Sales Market Share by Application (2012-2017)
Table Canada Cancer Treatment Drugs Sales by Manufacturer (2016-2017)
Figure Canada Cancer Treatment Drugs Sales Market Share by Manufacturer in 2016
Figure Canada Cancer Treatment Drugs Sales Market Share by Manufacturer in 2017
Table Canada Cancer Treatment Drugs Revenue by Manufacturer (2016-2017)
Figure Canada Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2016
Figure Canada Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2017
Table Canada Cancer Treatment Drugs Export and Import (2012-2017)
Figure Mexico Cancer Treatment Drugs Revenue and Growth (2012-2017)
Figure Mexico Cancer Treatment Drugs Sales and Growth (2012-2017)
Table Mexico Cancer Treatment Drugs Sales by Type (2012-2017)
Table Mexico Cancer Treatment Drugs Sales Market Share by Type (2012-2017)
Table Mexico Cancer Treatment Drugs Sales by Application (2012-2017)
Table Mexico Cancer Treatment Drugs Sales Market Share by Application (2012-2017)
Table Mexico Cancer Treatment Drugs Sales by Manufacturer (2016-2017)
Figure Mexico Cancer Treatment Drugs Sales Market Share by Manufacturer in 2016
Figure Mexico Cancer Treatment Drugs Sales Market Share by Manufacturer in 2017
Table Mexico Cancer Treatment Drugs Revenue by Manufacturer (2016-2017)
Figure Mexico Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2016
Figure Mexico Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2017
Table Mexico Cancer Treatment Drugs Export and Import (2012-2017)
Figure North America Cancer Treatment Drugs Sales, Revenue and Growth Rate (2017-2022)
Table North America Cancer Treatment Drugs Sales Forecast by Countries (2017-2022)
Table North America Cancer Treatment Drugs Market Share Forecast by Countries (2017-2022)
Figure United States Cancer Treatment Drugs Sales Forecast (2017-2022)
Figure Canada Cancer Treatment Drugs Sales Forecast (2017-2022)
Figure Mexico Cancer Treatment Drugs Sales Forecast (2017-2022)
Table North America Cancer Treatment Drugs Sales Forecast by Type (2017-2022)
Table North America Cancer Treatment Drugs Market Share Forecast by Type (2017-2022)
Table North America Cancer Treatment Drugs Sales Forecast by Application (2017-2022)
Table North America Cancer Treatment Drugs Market Share Forecast by Application (2017-2022)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cancer Treatment Drugs
Figure Manufacturing Process Analysis of Cancer Treatment Drugs
Figure Cancer Treatment Drugs Industrial Chain Analysis
Table Raw Materials Sources of Cancer Treatment Drugs Major Manufacturers in 2016
Table Major Buyers of Cancer Treatment Drugs
Table Distributors/Traders/ Dealers List

Table of Contents

Related reports :

(Apr 18)

Vitamin K2 is the term for a group of compounds called ‘menaquinones,’ which can be found mainly in dairy products. All K vitamins are simil...

(Apr 18)

"Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), is a glycoprotein enzyme encoded in humans by th...

(Apr 18)

"Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from l...

(Apr 18)

Epinephrine, also known as adrenalin or adrenaline, is a hormone, neurotransmitter and medication. Epinephrine is normally produced by both ...

(Apr 18)

A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent ...

(Apr 18)

Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at nigh...


NORTH AMERICA CANCER TREATMENT DRUGS MARKET BY MANUFACTURERS, COUNTRIES, TYPE AND APPLICATION, FORECAST TO 2022

Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Medicine and Pharmacy market as per your needs. Get the best of Medicine and Pharmacy research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*